MDS Pharma Services

Company Overview
MDS Pharma Services provides drug discovery and development services for the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process: Early stage—lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development; early clinical research—bioequivalence, Phases I-IIa, and bioanalysis; and late stage—global clinical development, Phases IIb-IV, and central lab. MDS Pharma Services offers the industry's most extensive selection of biochemical, cellular, tissue, organ and animal assays for use in profiling a compound's specificity and selectivity, and in understanding the potential for adverse events. The company also provides a range of global clinical development services, including clinical project management and monitoring, feasibility studies, data management, biostatistics, health economics and more.

Quick Facts
MDS Pharma Services
2011 30th Dr. SE
Bothell WA 98021

Featured Solutions

• Speed, communication and high-quality science for biopharmaceuticals by MDS Pharma Services
  In this case study, MDS Pharma Services provides Roche Pharmaceuticals with speedy turnaround and high-quality service on lot-to-lot validation and other biosafety tests needed for a Food and Drug Administration audit.
  
  
• Key tests for breakthrough blood safety system by MDS Pharma Services
  In this case study, MDS Pharma Services performs viral validations for Navigant Biotechnologies that help the company perfect the system, obtain Food and Drug Administration approval and move the product to market.
  
  
• How MDS Pharma Services creates dosage forms and transfers the technology to ... by MDS Pharma Services
  In this case study, MDS Pharma Services outlines how it created a new dosage form and manufacturing process for a global pharma company that wanted to replace a sugarcoated tablet with an immediate-release, aquaeous-film coated tablet produced by direct compression.
  
  
• Intelligent recruitment strategies for more on-time studies by MDS Pharma Services
  In this case study, MDS Pharma Services creates a recruitment strategy for a complicated double-blind safety and efficacy trial with 30 study sites—closing recruitment two weeks ahead of schedule for a project many considered impossible to run.
  
  
• Speed, communication and high-quality science from MDS Pharma Services by MDS Pharma Services
  In this case study, MDS Pharma Services supports Roche Pharmaceuticals to prepare for an FDA audit by undertaking lot-to-lot validation and other biosafety tests for reagents used in diagnostic kits.
  
  
• Smart support around the clock from MDS Pharma Services by MDS Pharma Services
  In this case study, MDS Pharma Services provides support around the clock to a pharmaceutical company conducting an eight-month treatment study of drug for patients diagnosed with a life-threatening blood disorder.
  
  
• The essentials of stability test services by MDS Pharma Services
  This white paper by MDS Pharma Services describes the testing that a drug must undergo before it is launched in the market.
  
  
• Foresight, formulation and technology transfer for high-volume drug ... by MDS Pharma Services
  This white paper by MDS Pharma Services features an interview with Brian McMillan, section head of formulation development, about foresight, formulation and technology transfer for high-volume drug manufacturing.
  
  
• Pharmotif Solutions: Smart decisions in discovery and new applications for ... by MDS Pharma Services
  According to this white paper by MDS Pharma Services, Pharmotif Solutions offers better methods of drug discovery and new applications development.
  
  
• Norman Share on the value of early adverse event profiling in animals by MDS Pharma Services
  This white paper by MDS Pharma Services is an interview on adverse event profiling with Dr. Norman Share, technical director of MDS.
  
  
• Paul Stach on the art and science of formulation pharmaceutics by MDS Pharma Services
  This white paper by MDS Pharma Services provides an overview of formulation development through an interview with Paul Stach, senior director of formulation manufacturing at MDS.
  
  
• Global approach to safety pharmacology by MDS Pharma Services
  This white paper by MDS Pharma Services is an interview with Dr. Stephane Milano, senior scientist of safety pharmacology at MDS, on taking a global approach to safety pharmacology.
  
  
• Method validation, experience and 'getting it right' the first time by MDS Pharma Services
  This white paper by MDS Pharma Services is an interview on method validation with Dr. Sheila Tenneson, MDS director of analytical development in the pharmaceutics division, who describes the role of validation in pharmaceutical development and validations performed at MDS facilities.
  
  
• Preformulation as the basis for effective formulation and drug stability by MDS Pharma Services
  This white paper by MDS Pharma Services describes preformulation services, which are designed to provide clients with as much relevant information as possible about the physical and sometimes chemical properties of their compounds before they select dosage forms.
  
  
• Fast, reliable lot-release testing with rigorous quality control by MDS Pharma Services
  This white paper by MDS Pharma Services describes how to achieve fast and reliable lot-release testing.
  
  
• Viral clearance process evaluation by MDS Pharma Services
  This white paper by MDS Pharma Services describes the process and the complications involved in the viral clearance process evaluation.
  
  

• Screening for CYP3A4 induction potential by MDS Pharma Services
  In this application note, MDS Pharma Services describes how its model for screening CYP3A4 induction, which is based on genetically engineered human cells, provides greater benefits over previous models in generating fast, high-volume and consistently reproducible data.